On-Demand Webinar

Perfusion Applications in Mobius® Bioreactors

Duration: 1 Hour
Speaker: Michael Cunningham, Process Development Scientist, Merck

Abstract: Manufacturing of biotherapeutics is evolving to encompass widespread use of single-use technologies in order to control costs and optimize operational flexibility. Single-use bioreactors are commonly used for both process development and commercial production of monoclonal antibodies (mAbs) and recombinant proteins. While utilization of these systems have routinely employed batch and fed-batch modes of operation generate recombinant products from mammalian expression systems, the use of the bioreactor for perfusion in this operational space has yet to be sufficiently characterized and implemented.

Register to Watch Now